冠動脈性心疾患および関連する手順. 国立病院退院調査データ 国立病院退院調査データ
M Feinleib1, R J Havlik, R F Gillum
1National Center for Health Statistics, Centers for Disease Control, Hyattsville, Maryland 20782.
Circulation
|June 1, 1989
まとめ
1984年から1986年にかけて,冠動脈疾患の診断で退院した患者の数は増加し,不安定な胸痛と冠動脈バイパス移植や血管新生手術などの手術の件数が著しく増加しました.
科学分野:
- 心血管疾患の疫学について
- 医療サービス 研究 医療サービス
- 医療手続きのトレンド
背景:
- 国立病院退院調査のデータは,心血管疾患 (CVD) の傾向についての洞察を提供します.
- 総合的な退院率は減少したが,冠動脈疾患 (CAD) 関連の診断は増加した.
- これらの傾向を理解することは,公衆衛生と医療資源の配分において極めて重要です.
研究 の 目的:
- 手術を必要とする心血管疾患の退院傾向を分析する.
- 不安定性胸痛や急性心筋梗塞などの特定の診断における変化を調べる.
- 冠動脈バイパス移植 (CABG) や冠動脈血管新生手術などの外科的介入の利用を追跡する.
主な方法:
- 全国病院退院調査 (NHDS) の横断データとトレンドデータを活用した.
- 1979年から1986年までの特定の心血管疾患の診断と処置に関する退院データを分析した.
- 高齢層の男性と女性の比率など,アンギナ診断のための人口統計学的変動を調べた.
主要な成果:
- 冠動脈関連の診断が増加し,特に不安定な胸痛が増加し,慢性発血性心臓病は減少した.
- 冠動脈バイパス移植手術の退院数は2倍になり,冠動脈血管新生手術の件数は劇的に増加しました.
- 急性心筋梗塞の退院率は安定したが,平均滞在期間は減少した.
- 発作不良や心不全は一般的な合併症であり,高齢の女性はアンギナ出血率が高かった.
結論:
- 病院での入院の傾向は,冠動脈疾患の介入療法への移行を示しています.
- 不安定性アンギナの増加は,診断方法を含む潜在的な原因のさらなる調査を正当化しています.
- 継続的なCADの排出傾向と手続き利用のモニタリングは,医療計画に不可欠です.
関連する概念動画
01:31Discharge Summary Forms
The discharge summary is crucial as it enables a smooth transition from a healthcare facility to a patient's home or another care setting. This critical document facilitates seamless continuity of care, ensuring patients receive the necessary support and attention.
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
Here's a detailed look at the key components and guidelines for preparing a discharge summary:
01:28Cardiac Catheterization I: Pre-Procedure Overview
Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
01:26Coronary Artery Disease IV: Preventive Measures
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
01:27Coronary Artery Disease V: Interprofessional Care
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
01:30Acute Coronary Syndrome III: Diagnostic Studies
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
01:28Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...